Evolus (EOLS) Interest Coverage Ratio (2017 - 2026)

Evolus (EOLS) posted Interest Coverage Ratio of 1.72 for Q1 2026, down 440.72% on a QoQ basis from 0.51 in Q4 2025, and up 49.87% year-over-year from 1.15 in Q1 2025.

Evolus (EOLS) Interest Coverage Ratio (2017 - 2026) Analysis & Trends

Evolus' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.72 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 49.87% year-over-year to 1.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.17 (up 50.41% YoY) and the FY2025 annual result came in at 1.66, down 501.94% from the prior year.
  • Interest Coverage Ratio was 1.72 for Q1 2026 at Evolus, down from 0.51 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.51 in Q4 2025 and bottomed at 4.58 in Q3 2023.
  • A 5-year average of 2.25 and a median of 1.9 in 2024 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 21586.71% — and 2025, when it jumped 173.92%.
  • Evolus' Interest Coverage Ratio stood at 4.53 in 2022, then surged by 61.29% to 1.75 in 2023, then jumped by 61.0% to 0.68 in 2024, then jumped by 173.92% to 0.51 in 2025, then tumbled by 440.72% to 1.72 in 2026.
  • Business Quant data shows EOLS's Interest Coverage Ratio at 1.72 in Q1 2026, 0.51 in Q4 2025, and 2.81 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 13.44
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.81
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 0.18
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -0.07
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 0.33
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 5.11
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -1.72

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.72
Dec 31, 2025 0.51
Sep 30, 2025 -2.81
Jun 30, 2025 -0.85
Mar 31, 2025 -3.44
Dec 31, 2024 -0.68
Sep 30, 2024 -3.25
Jun 30, 2024 -1.64
Mar 31, 2024 -1.90
Dec 31, 2023 -1.75
Sep 30, 2023 -4.58
Jun 30, 2023 -2.53
Mar 31, 2023 -2.37
Dec 31, 2022 -4.53
Sep 30, 2022 -4.22
Jun 30, 2022 -1.37
Mar 31, 2022 -1.05
Dec 31, 2021 16.13
Sep 30, 2021 -0.02
Jun 30, 2021 -1.39